ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Cross Above 50-Day Moving Average – Here’s Why

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)’s share price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $82.15 and traded as high as $85.68. ProShares Ultra Nasdaq Biotechnology shares last traded at $84.7260, with a volume of 2,951 shares trading hands.

ProShares Ultra Nasdaq Biotechnology Stock Performance

The company has a market capitalization of $78.80 million, a PE ratio of 20.68 and a beta of 1.25. The stock’s 50 day moving average is $82.15 and its 200 day moving average is $81.29.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

Institutional investors have recently modified their holdings of the business. Franklin Resources Inc. bought a new stake in ProShares Ultra Nasdaq Biotechnology during the 2nd quarter worth approximately $32,000. Citadel Advisors LLC bought a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 3rd quarter valued at about $307,000. Kaizen Financial Strategies bought a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 4th quarter valued at $424,000. Finally, Palumbo Wealth Management LLC bought a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 3rd quarter valued at $766,000.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.